Ilja Bontjer

4.1k citations

31 papers · 735 indexed · h-index 15

Virology top 2%
- HIV Research and Treatment 23
Immunology top 10%
- Immune Cell Function and Interaction 6
- T-cell and B-cell Immunology 4
Infectious Diseases top 10%
- HIV/AIDS drug development and treatment 9
- SARS-CoV-2 and COVID-19 Research 3
Molecular Biology
Epidemiology
- Herpesvirus Infections and Treatments 4
- Virology and Viral Diseases 3
Ecology
- Bacteriophages and microbial interactions 3

Co-authors: Rogier W. Sanders Ben Berkhout Evert de Vries Jannie Borst Stephen W. G. Tait Dirk Eggink Johannes P. M. Langedijk Ineke Braakman
Cited by: Virology Immunology Infectious Diseases
Journals: Journal of Virology (9 papers)Journal of Biological Chemistry (4 papers)Retrovirology (3 papers)
Partner nations: Netherlands United States United Kingdom

In The Last Decade

Ilja Bontjer

30 papers receiving 729 citations

Peers

Countries citing papers authored by Ilja Bontjer

Since Specialization

Citations

This map shows the geographic impact of Ilja Bontjer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ilja Bontjer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ilja Bontjer more than expected).

Fields of papers citing papers by Ilja Bontjer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ilja Bontjer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ilja Bontjer. The network helps show where Ilja Bontjer may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Ilja Bontjer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ilja Bontjer Line = papers co-authored together Ilja Bontjer links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Short CDRL1 in intermediate VRC01-like mAbs is not sufficient to overcome key glycan barriers on HIV-1 Env Journal of Virology ·Parul Agrawal,Maria L. Knudsen,Anna J. MacCamy,Nicholas K. Hurlburt,Arineh Khechaduri,Sushma Susik,Joyce Coella Mihindou,Sandra McFarlane,Andrew B. Stuart,Ilja Bontjer,Xiaoying Shen,David C. Montefiori,Harry B. Gristick,Pamela J. Björkman,Kerry M. Brennan,Marie Pancera,Leonidas Stamatatos	2024	0
2	Bispecific antibodies combine breadth, potency, and avidity of parental antibodies to neutralize sarbecoviruses iScience ·Soha Pervaiz,Kwinten Sliepen,Victor Yin,Mitch Brinkkemper,Anette Sigler,昇多賀,Jonathan L. Torres,Sandhya Bangaru,Judith A. Burger,Meliawati Poniman,Ilja Bontjer,Joey H. Bouhuijs,Sebastian Graf Kielmansegg,Dirk Eggink,Andrew B. Ward,Albert J. R. Heck,Marit J. van Gils,Rogier W. Sanders,Janke Schinkel	2023	7
3	Innate cell markers that predict anti-HIV neutralizing antibody titers in vaccinated macaques Cell Reports Medicine ·F. Fallah,Pauline Maisonnasse,Rahbar Kiyarash,Monica Tolazzi,Yoann Aldon,Nathalie Dereuddre‐Bosquet,Mariangela Cavarelli,Anne‐Sophie Beignon,HSIN HSIU-SAN,Anne-Sophie Gallouët,D.N. Fass,Gabriel Ozorowski,Andrew B. Ward,Ilja Bontjer,Paul F. McKay,Robin J. Shattock,Gabriella Scarlatti,Rogier W. Sanders,Roger Le Grand	2022	2
4	A third SARS-CoV-2 spike vaccination improves neutralization of variants-of-concern npj Vaccines ·Mitch Brinkkemper,Philip J. M. Brouwer,Pauline Maisonnasse,Marloes Grobben,Tom G. Caniels,Meliawati Poniman,Judith A. Burger,Ilja Bontjer,Melissa Oomen,Joey H. Bouhuijs,Félix Armando Nuñez,Julien Villaudy,Yme U. van der Velden,Kwinten Sliepen,Marit J. van Gils,Roger Le Grand,Rogier W. Sanders	2021	8
5	Potent Induction of Envelope-Specific Antibody Responses by Virus-Like Particle Immunogens Based on HIV-1 Envelopes from Patients with Early Broadly Neutralizing Responses Journal of Virology ·いづみ吉沢,Ilja Bontjer,Núria Gonzàlez,María Pernas,María Paula Wills-Buitrago,Àlex Olvera,José M. Miró,Christian Brander,José Alcamı́,Rogier W. Sanders,Víctor Sánchez-Merino,Eloísa Yuste	2021	10
6	Interplay of diverse adjuvants and nanoparticle presentation of native-like HIV-1 envelope trimers npj Vaccines ·Kwinten Sliepen,Edith E. Schermer,Ilja Bontjer,Judith A. Burger,J.L. Rosner,Tomás Queiroz Ferreira Barata,Philip J. M. Brouwer,Monica Tolazzi,Attila Farsang,Dietmar Katinger,John P. Moore,Gabriella Scarlatti,Robin J. Shattock,Quentin J. Sattentau,Rogier W. Sanders	2021	15
7	Intramolecular quality control: HIV-1 envelope gp160 signal-peptide cleavage as a functional folding checkpoint Cell Reports ·亦桐,黃頌顯,Ilja Bontjer,Guus van Zadelhoff,Aafke Land,Ema T. Crooks,James Μ. Binley,Rogier W. Sanders,Ineke Braakman	2021	11
8	HIV-1 anchor inhibitors and membrane fusion inhibitors target distinct but overlapping steps in virus entry Journal of Biological Chemistry ·Dirk Eggink,Ilja Bontjer,Steven W. de Taeye,Johannes P. M. Langedijk,Ben Berkhout,Rogier W. Sanders	2019	29
9	D-102 Presenting native-like HIV-1 envelope trimers on ferritin nanoparticles improves their immunogenicity JAIDS Journal of Acquired Immune Deficiency Syndromes ·Kwinten Sliepen,Gabriel Ozorowski,Judith A. Burger,Thijs van Montfort,Melissa Stunnenberg,Ilja Bontjer,Celia C. LaBranche,David C. Montefiori,John P. Moore,Andrew B. Ward,Rogier W. Sanders	2016	2
10	HIV-1 Escape from a Peptidic Anchor Inhibitor through Stabilization of the Envelope Glycoprotein Spike Journal of Virology ·Dirk Eggink,Steven W. de Taeye,Ilja Bontjer,Per Johan Klasse,Johannes P. M. Langedijk,Ben Berkhout,Rogier W. Sanders	2016	15
11	Comparative Immunogenicity of Evolved V1V2-Deleted HIV-1 Envelope Glycoprotein Trimers PLoS ONE ·Ilja Bontjer,Mark Melchers,Tommy Tong,Thijs van Montfort,Dirk Eggink,David C. Montefiori,William C. Olson,John P. Moore,James Μ. Binley,Ben Berkhout,Rogier W. Sanders	2013	6
12	Targeting HIV-1 Envelope Glycoprotein Trimers to B Cells by Using APRIL Improves Antibody Responses Journal of Virology ·Mark Melchers,Ilja Bontjer,Tommy Tong,Nancy P. Y. Chung,Per Johan Klasse,Dirk Eggink,David C. Montefiori,Nenad Petrović,Andrea Cerutti,William C. Olson,Ben Berkhout,James Μ. Binley,John P. Moore,Rogier W. Sanders	2011	39
13	A stabilized HIV-1 envelope glycoprotein trimer fused to CD40 ligand targets and activates dendritic cells Retrovirology ·Mark Melchers,Katie Matthews,Robert P. de Vries,Dirk Eggink,Thijs van Montfort,Ilja Bontjer,Carolien E. van de Sandt,鸿福殷,Ben Berkhout,John P. Moore,Rogier W. Sanders	2011	28
14	Stabilized HIV-1 Envelope Glycoprotein Trimers Lacking the V1V2 Domain, Obtained by Virus Evolution Journal of Biological Chemistry ·Ilja Bontjer,Mark Melchers,Dirk Eggink,鸿福殷,John P. Moore,Ben Berkhout,Rogier W. Sanders	2010	20
15	Evolution Rescues Folding of Human Immunodeficiency Virus-1 Envelope Glycoprotein GP120 Lacking a Conserved Disulfide Bond Molecular Biology of the Cell ·Rogier W. Sanders,Shang‐Te Danny Hsu,Eelco van Anken,Gholam abbas Roostayi,NANCY C. ANDREASEN,Ilja Bontjer,Aafke Land,Ineke Braakman,Alexandre M. J. J. Bonvin,Ben Berkhout	2008	10
16	Only Five of 10 Strictly Conserved Disulfide Bonds Are Essential for Folding and Eight for Function of the HIV-1 Envelope Glycoprotein Molecular Biology of the Cell ·Eelco van Anken,Rogier W. Sanders,Gholam abbas Roostayi,Aafke Land,Ilja Bontjer,Stefan M V. Freund,Alexey A. Nabatov,William A. Paxton,Ben Berkhout,Ineke Braakman	2008	39
17	Evolutionary stability of MHC class II haplotypes in diverse rhesus macaque populations Immunogenetics ·Gaby G. M. Doxiadis,Ńel Otting,Natasja G. de Groot,Nanine de Groot,Davi Sarcinelli Vasconcelos,Riet Noort,Ernst J. Verschoor,Ilja Bontjer,Ronald E. Bontrop	2003	66
18	TRAIL Receptor and CD95 Signal to Mitochondria via FADD, Caspase-8/10, Bid, and Bax but Differentially Regulate Events Downstream from Truncated Bid Journal of Biological Chemistry ·Almendra Ornela Huapaya Sayán,Evert de Vries,Stephen W. G. Tait,Ilja Bontjer,Jannie Borst	2002	52
19	Bcl-2 Family Member Bfl-1/A1 Sequesters Truncated Bid to Inhibit Its Collaboration with Pro-apoptotic Bak or Bax Journal of Biological Chemistry ·Almendra Ornela Huapaya Sayán,Evert de Vries,Stephen W. G. Tait,Ilja Bontjer,Jannie Borst	2002	142
20	Presence of major genes for resistance to Globodera pallida in wild tuber bearing Solanum species and their location on the potato genome. Socio-Environmental Systems Modeling ·Pieter J. Wolters,Martin Hughes1,Ilja Bontjer,Jeroen Rouppe van der Voort,L.T. Colon,Coosje Hoogendoorn	1998	2

About Ilja Bontjer

Ilja Bontjer is a scholar working on Virology, Infectious Diseases, Immunology, Hepatology and Epidemiology, having authored 31 papers that have together received 735 indexed citations. Recurring topics across this work include HIV Research and Treatment (23 papers), HIV/AIDS drug development and treatment (9 papers), Immune Cell Function and Interaction (6 papers), Herpesvirus Infections and Treatments (4 papers), T-cell and B-cell Immunology (4 papers), SARS-CoV-2 and COVID-19 Research (3 papers), Bacteriophages and microbial interactions (3 papers) and Virology and Viral Diseases (3 papers). The work is most often cited by research in Virology (353 citations), Immunology (256 citations), Infectious Diseases (191 citations), Molecular Biology (321 citations) and Epidemiology (128 citations). Ilja Bontjer has collaborated with scholars based in Netherlands, United States and United Kingdom. Frequent co-authors include Rogier W. Sanders, Ben Berkhout, Evert de Vries, Jannie Borst, Stephen W. G. Tait, Dirk Eggink, Johannes P. M. Langedijk, Ineke Braakman, Ernst J. Verschoor and Aafke Land. Their work appears in journals such as Journal of Virology, Journal of Biological Chemistry, Retrovirology, Molecular Biology of the Cell and Journal of General Virology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact